Drug Profile
Research programme: antimalarials - Ferrer/Medicines for Malaria Venture
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Ferrer; Medicines for Malaria Venture
- Developer Medicines for Malaria Venture
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Malaria in Australia
- 12 Jul 2010 Early research in Malaria in Australia (unspecified route)